Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

安乃近滴鼻液 - NMPA Drug Approval Details

Approvals/NMPA/Metamizole Sodium Nasal Drops

Approved

化学药品

Metamizole Sodium Nasal Drops

慈象药业湖北有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 25, 2015
Approval ID: 7LeafseD7pC
Company: 慈象药业湖北有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeafseD7pC
Approval Number: 国药准字H42022530
Generic Name: 安乃近滴鼻液
Generic Name En: Metamizole Sodium Nasal Drops
Drug Type: 化学药品
Dosage Form: 鼻用制剂(滴鼻剂)
Strength: 3ml:0.6g
Reg Date: 2015-09-25
Company Name: 慈象药业湖北有限公司
Production Company Address: 湖北省潜江市章华南路特1号
Company Detail Path: /organization/ci-xiang-yao-ye-hu-bei-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 25, 2015

Approval ID

7LeafseD7pC

Type

化学药品

Back to NMPA Approvals